Safety and Efficacy of Monoclonal Antibody VIS410 in Adults with Uncomplicated Influenza A Infection: Results from a Randomised, Double-Blind, Placebo-Controlled Study

SSRN Electronic Journal ◽

10.2139/ssrn.3271424 ◽

2018 ◽

Author(s):

Ellie Hershberger ◽

Susan Sloan ◽

Kristin Narayan ◽

Catherine A. Hay ◽

Patrick Smith ◽

...

Keyword(s):

Monoclonal Antibody ◽

Influenza A ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734858436.793573735 ◽

2020 ◽

Author(s):

Graham Pawelec

Keyword(s):

Monoclonal Antibody ◽

Influenza A ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy

Download Full-text

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

EBioMedicine ◽

10.1016/j.ebiom.2018.12.051 ◽

2019 ◽

Vol 40 ◽

pp. 574-582 ◽

Cited By ~ 29

Author(s):

Ellie Hershberger ◽

Susan Sloan ◽

Kristin Narayan ◽

Catherine A. Hay ◽

Patrick Smith ◽

...

Keyword(s):

Monoclonal Antibody ◽

Influenza A ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718532439.793525446 ◽

2016 ◽

Author(s):

Mark Obermann ◽

Dagny Holle

Keyword(s):

Monoclonal Antibody ◽

Calcitonin Gene Related Peptide ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Related Peptide ◽

Calcitonin Gene

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718532439.793500323 ◽

2014 ◽

Author(s):

Shuu-Jiun Wang

Keyword(s):

Monoclonal Antibody ◽

Calcitonin Gene Related Peptide ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Related Peptide ◽

Calcitonin Gene

Download Full-text

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

The Lancet Neurology ◽

10.1016/s1474-4422(14)70128-0 ◽

2014 ◽

Vol 13 (9) ◽

pp. 885-892 ◽

Cited By ~ 227

Author(s):

David W Dodick ◽

Peter J Goadsby ◽

Egilius L H Spierings ◽

Joel C Scherer ◽

Steven P Sweeney ◽

...

Keyword(s):

Monoclonal Antibody ◽

Calcitonin Gene Related Peptide ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Related Peptide ◽

Calcitonin Gene

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732407.793547378 ◽

2018 ◽

Author(s):

Maria Laura Bertolaccini

Keyword(s):

Systemic Lupus Erythematosus ◽

Monoclonal Antibody ◽

Lupus Erythematosus ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo ◽

B Cell Activating Factor

Download Full-text

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2011.04818.x ◽

2011 ◽

Vol 34 (8) ◽

pp. 868-877 ◽

Cited By ~ 27

Author(s):

J. F. Tack ◽

P. B. Miner ◽

L. Fischer ◽

M. S. Harris

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Safety and Efficacy of a New 3.3g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(09)79361-4 ◽

2009 ◽

Vol 2009 ◽

pp. 110-111

Author(s):

M.F. Picco

Keyword(s):

Ulcerative Colitis ◽

Tablet Formulation ◽

Controlled Study ◽

Active Ulcerative Colitis ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study

Journal of Medicinal Food ◽

10.1089/jmf.2017.4172 ◽

2018 ◽

Vol 21 (11) ◽

pp. 1120-1128 ◽

Cited By ~ 2

Author(s):

Muhammed Majeed ◽

Shaheen Majeed ◽

Kalyanam Nagabhushanam ◽

Sivakumar Arumugam ◽

Anurag Pande ◽

...

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Multienzyme Complex ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13748 ◽

2018 ◽

Vol 85 (2) ◽

pp. 304-315 ◽

Cited By ~ 13

Author(s):

Joanne Ellis ◽

Andre Maurik ◽

Lea Fortunato ◽

Sophie Gisbert ◽

Keguan Chen ◽

...

Keyword(s):

Monoclonal Antibody ◽

Healthy Subjects ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text